BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 27, 2005
View Archived Issues
Neuroprotective antiinflammatory effects of the MLK inhibitor CEP-1347 shown in vitro and in vivo
Read More
The potent antitumor candidate XR-5944 displays a unique mechanism of action
Read More
AGS-PSCA: a candidate for clinical trials in prostate, pancreatic cancers
Read More
Transgenomic to provide additional nucleic acid products to Geron
Read More
Second phase review in Europe of Johnson & Johnson's acquisition of Guidant
Read More
Japan Tobacco and Torii pharma production facilities to merge
Read More
Exelixis submits IND for XL-820
Read More
Orphan drug designation for doxorubicin Transdrug in primary liver cancer
Read More
ThromboView update
Read More
Alizyme completes thorough cardiovascular safety trial of renzapride
Read More
Japanese approval of biopharmaceutical using GroPep's Cell Culture Products
Read More
Enrollment completed in diabetes study of Diamyd in children
Read More
Phase IIb study of Hamilton's HL-0812 supported by Series A financing
Read More
Myriad presents new data on anticancer drug candidates MPC-2130 and MPC-6827
Read More
Recent patents describe therapeutic agents for asthma
Read More
New immunomodulatory agents disclosed by General Atomics
Read More
Novel agents for urinary incontinence and renal disorders imparted in recent patents
Read More
New data on the safety profile of 17-AAG in patients with solid tumors
Read More
Discovery and preclinical profile of dual VEGFR-2/FGFR-1 kinase inhibitors
Read More
PU-H58, a highly potent and selective Hsp90 inhibitor
Read More
Promising results reported for SGN-40 in recurrent multiple myeloma
Read More
Preclinical evidence supports the use of CYC-202 in multiple myeloma
Read More
Update on lenalidomide in multiple myeloma
Read More
MP4 safe in human volunteers
Read More
